INTS Intensity Tx: Multiplikator nilai perusahaan marang pendapatan

Logo perusahaan publik Intensity Therapeutics Inc (INTS)

The virtual business model of Intensity Therapeutics (INTS), which relies on external contractors for synthesis and testing, impacts profitability. The company's enterprise value to revenue (EV/Revenue) valuation on GURU.Markets reflects the asset's dynamics, where 0.00 marks a new level. Risks are associated with the complexity of tumor injections; however, a stable R&D workforce and the hiring of specialized managers support growth potential.

Nilai perusahaan marang pendapatan: Intensity Tx (INTS) kanggo 23.11.2025 - 20.11.2026

Intensity Tx - rincian analitis lan metrik utama (INTS)

- rega saham lan konsensus proyeksi valuasi:
Analisis wiwitan perusahaan:Intensity Therapeutics Inc INTS
Sampel barang Intensity Therapeutics Inc

The efficacy of the INT230-6 therapy directly impacts the capitalization of Intensity Therapeutics (INTS), shaping market expectations for its revenue. By analyzing the enterprise value-to-revenue multiple, an investor assesses the total business (EV) net of debt, which allows for the removal of leverage's influence on the fundamental value of sales. Identifying sustainable price corridors on this chart helps avoid value traps and determine safe entry points.

Analisis pesaing Intensity Therapeutics

IBRX (immunitybio.com) - Rasio nilai perusahaan marang pendapatan|Immunocore Corp (IMCR) - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Janux Pharma (JANX)|Nilai perusahaan marang pendapatan RCUS|ZYME - Rasio nilai perusahaan marang dodolan|Nilai perusahaan marang pendapatan TNGX (Tango Pharma)|Koefisien nilai perusahaan marang pendapatan IOVA|Multiplikator EV/Sales IMTX (Immatics)|Nilai bisnis marang pendapatan XNCR|compasstherapeutics.com - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Replimune Inc.|Lyell Immunopharma (LYEL) - Rasio nilai perusahaan marang pendapatan|Innate Pharma S.A. - Nilai bisnis marang pendapatan|PYXS (Pyxis) - Multiplikator EV/Sales|Multiplikator EV/Sales cgen.com|Rasio nilai perusahaan marang pendapatan IO Biotech (IOBT)|STRO: Nilai perusahaan marang volume dodolan|MiNK Therapeutics Inc. - Nilai perusahaan marang pendapatan|werewolftx.com (HOWL) - Multiplikator nilai perusahaan marang pendapatan|Immix Biopharma Inc. - Multiplikator EV/Sales|ALXO - Multiplikator EV/Sales|CUE: Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan PDSB|Rasio nilai perusahaan marang pendapatan Sonnet BioTherapeutics Holdings|MAIA Biotechnology (MAIA) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales LIMN|Multiplikator EV/Sales Lava Tx (LVTX)|Multiplikator EV/Sales NXTC (NextCure Corporation)|Nilai bisnis marang pendapatan LPTX|Sensei Biotherapeutics Inc - Multiplikator EV/Sales|TOVX: Rasio nilai perusahaan marang pendapatan|gritstonebio.com (GRTS) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan KA|Rasio nilai perusahaan marang pendapatan NexImmune, Inc.|Rasio nilai perusahaan marang pendapatan TSBX (Turnstone Biologics)|Nilai perusahaan marang pendapatan VCNX (Vaccinex, Inc.)|Koefisien nilai perusahaan marang pendapatan HARP